The Peptide-Based Vaccines Research Group was established in 2021 with the support of the MTA’s Momentum Programme. The peptides, peptide derivatives and conjugates produced in the group are used in various research areas. New formulation strategies are being developed to enhance the biological activity of synthetic peptides and to maintain their stability. Using colloidal chemistry systems, we develop peptide delivery platforms with several advantageous properties such as target delivery, programmed drug release and enhanced immunogenicity.
Main research topics:
– Synthetic vaccines
– Dendritic cell targeting with peptides
– Antimicrobial peptides and peptide derivatives
– Synthetic vaccines for immunotherapy
– Melanoma-specific peptides and peptide derivatives
Homepage of the Biological Soft Matter Platform
Head of the research group
Kata Horvati